Trial Profile

Clinical Study of Personalized mRNA Tumor Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Squamous Carcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma and Colorectal Adenocarcinoma

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 06 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SW 1115C3 (Primary)
Indications Adenocarcinoma; Carcinoma; Colon cancer; Colorectal cancer; Digestive system neoplasms; Gastric cancer; Oesophageal cancer; Pancreatic cancer; Rectal cancer; Squamous cell cancer
Focus Adverse reactions; First in man

22 Jun 2020 New trial record
31 May 2020 Results (n=3; as of 1 Feb 2020) presented at the 56th Annual Meeting of the American Society of Clinical Oncology.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com